Soluble biomarkers like sNfL and sGFAP can improve MS care by providing insights into disease activity and progression through simple blood tests. sNfL and sGFAP levels enhance predictive models for ...
Scientists have identified two previously unknown biological subtypes of multiple sclerosis (MS) using artificial intelligence, a discovery that could help doctors tailor treatments more precisely to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback